Healthcare -
Biotechnology - NASDAQ - US
$ 0.96
-5.88 %
$ 200 M
Market Cap
-1.35
P/E
SGMO - CASH FROM OPERATIONS
Cash from Operations SGMO - Sangamo Therapeutics, Inc.
-225 M
LAST VALUE
1.82%
2 YEAR CAGR
-47.80%
5 YEAR CAGR
-27.71%
10 YEAR CAGR